Biologics Contract Manufacturing Asia 2025
September 10-11, 2025
Sands Expo & Convention Centre, Marina Bay Sands, Singapore
We’re excited to be exhibiting at the BCMA Singapore conference this year! Don’t miss “Bridging Early Development and Commercial Manufacturing Across Global Sites” by Jennifer Kuan 官振儀, PhD, Vice President, Taiwan Operations.
In addition, Bora Biologics has been shortlisted for 2 Awards at the Asia Pacific Biologics CDMO Excellence Awards 2025:
🏆 Best Biologics CDMO Award: Analytical Services
🏆 Best Biologics CDMO Award: Scale-Up
As a global CDMO, Bora Biologics provides agile, end-to-end biologics solutions—backed by over 100 successful cGMP manufacturing batches and an FDA-registered facility in the U.S.
Our expertise spans early-phase development to late-stage manufacturing, including an FDA-licensed and Health Canada–approved product.
If you need a CDMO partner with mammalian and microbial expertise, we encourage you to connect with us in advance or at the show.